Jasper Therapeutics Stock Forecast, Price & News

Jasper Therapeutics (NASDAQ:JSPR) Frequently Asked Questions

Is Jasper Therapeutics a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Jasper Therapeutics in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Jasper Therapeutics stock.
View analyst ratings for Jasper Therapeutics or view top-rated stocks.

What stocks does MarketBeat like better than Jasper Therapeutics?

Wall Street analysts have given Jasper Therapeutics a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Jasper Therapeutics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

What price target have analysts set for JSPR?

3 Wall Street analysts have issued 12 month price objectives for Jasper Therapeutics' shares. Their forecasts range from $19.00 to $21.00. On average, they expect Jasper Therapeutics' share price to reach $20.00 in the next year. This suggests a possible upside of 74.1% from the stock's current price.
View analysts' price targets for Jasper Therapeutics or view top-rated stocks among Wall Street analysts.

Who are some of Jasper Therapeutics' key competitors?

Some companies that are related to Jasper Therapeutics include Tarsus Pharmaceuticals (TARS), Aerie Pharmaceuticals (AERI), CEL-SCI (CVM), Cellectis (CLLS), Passage Bio (PASG), Ambrx Biopharma (AMAM), Jounce Therapeutics (JNCE), Innate Pharma (IPHYF), Innate Pharma (IPHA), Gritstone bio (GRTS), Compugen (CGEN), Autolus Therapeutics (AUTL), Athira Pharma (ATHA), Poseida Therapeutics (PSTX) and Lineage Cell Therapeutics (LCTX).
View all of JSPR's competitors.

What is Jasper Therapeutics' stock symbol?

Jasper Therapeutics trades on the NASDAQ under the ticker symbol "JSPR."

How do I buy shares of Jasper Therapeutics?

Shares of JSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Jasper Therapeutics' stock price today?

One share of JSPR stock can currently be purchased for approximately $11.49.

How much money does Jasper Therapeutics make?

Jasper Therapeutics has a market capitalization of $143.63 million.

How many employees does Jasper Therapeutics have?

Jasper Therapeutics employs 3 workers across the globe.

Where are Jasper Therapeutics' headquarters?

Jasper Therapeutics is headquartered at 1177 AVENUE OF THE AMERICAS FL 40, NEW YORK NY, 10036.

How can I contact Jasper Therapeutics?

Jasper Therapeutics' mailing address is 1177 AVENUE OF THE AMERICAS FL 40, NEW YORK NY, 10036. The company can be reached via phone at 212-823-1900.